INS and hyperinsulinism: As hyperinsulinemia decreases IGF-binding protein–1 (IGFBP-1) and IGFBP-2 levels, insulin may reduce certain IGFBP levels and increase bioavailable IGF levels to indirectly enhance the IGF–IGF-1R signaling pathway.